View in EDS

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.

Saved in:
Bibliographic Details
Title: FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
Authors: Castillo-Castrejon M; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Sankofi BM; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Murguia SJ; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Udeme AA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Cen HH; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Xia YH; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Thomas NS; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Berry WL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Jones KL; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital and McGill University, Montreal, QC, Canada., Zahedi RP; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, R3E 3P4, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.; CancerCare Manitoba Research Institute, Winnipeg, MB, R3E 0V9, Canada., Borchers CH; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Gerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, H4A 3J1, Canada.; Department of Pathology, McGill University, Montreal, QC, H3A 2B4, Canada., Johnson JD; Life Sciences Institute, University of British Columbia, Vancouver, Canada., Wellberg EA; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA. elizabeth-wellberg@ouhsc.edu.
Source: Breast cancer research : BCR [Breast Cancer Res] 2023 Aug 22; Vol. 25 (1), pp. 99. Date of Electronic Publication: 2023 Aug 22.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37608351
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Castillo-Castrejon+M%22">Castillo-Castrejon M</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.<br /><searchLink fieldCode="AU" term="%22Sankofi+BM%22">Sankofi BM</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.<br /><searchLink fieldCode="AU" term="%22Murguia+SJ%22">Murguia SJ</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.<br /><searchLink fieldCode="AU" term="%22Udeme+AA%22">Udeme AA</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.<br /><searchLink fieldCode="AU" term="%22Cen+HH%22">Cen HH</searchLink>; Life Sciences Institute, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Xia+YH%22">Xia YH</searchLink>; Life Sciences Institute, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Thomas+NS%22">Thomas NS</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.<br /><searchLink fieldCode="AU" term="%22Berry+WL%22">Berry WL</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.<br /><searchLink fieldCode="AU" term="%22Jones+KL%22">Jones KL</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA.<br /><searchLink fieldCode="AU" term="%22Richard+VR%22">Richard VR</searchLink>; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital and McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Zahedi+RP%22">Zahedi RP</searchLink>; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, R3E 3P4, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.; CancerCare Manitoba Research Institute, Winnipeg, MB, R3E 0V9, Canada.<br /><searchLink fieldCode="AU" term="%22Borchers+CH%22">Borchers CH</searchLink>; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, R3E 3P4, Canada.; Gerald Bronfman Department of Oncology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, H3T 1E2, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, H4A 3J1, Canada.; Department of Pathology, McGill University, Montreal, QC, H3A 2B4, Canada.<br /><searchLink fieldCode="AU" term="%22Johnson+JD%22">Johnson JD</searchLink>; Life Sciences Institute, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Wellberg+EA%22">Wellberg EA</searchLink>; Department of Pathology, University of Oklahoma Health Sciences Center, 975 NE 10th Street BRC 309, Oklahoma City, OK, 73104, USA. elizabeth-wellberg@ouhsc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100927353%22">Breast cancer research : BCR</searchLink> [Breast Cancer Res] 2023 Aug 22; Vol. 25 (1), pp. 99. <i>Date of Electronic Publication: </i>2023 Aug 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100927353 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-542X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214655411%22">14655411 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37608351
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13058-023-01699-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 99
    Titles:
      – TitleFull: FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Castillo-Castrejon M
      – PersonEntity:
          Name:
            NameFull: Sankofi BM
      – PersonEntity:
          Name:
            NameFull: Murguia SJ
      – PersonEntity:
          Name:
            NameFull: Udeme AA
      – PersonEntity:
          Name:
            NameFull: Cen HH
      – PersonEntity:
          Name:
            NameFull: Xia YH
      – PersonEntity:
          Name:
            NameFull: Thomas NS
      – PersonEntity:
          Name:
            NameFull: Berry WL
      – PersonEntity:
          Name:
            NameFull: Jones KL
      – PersonEntity:
          Name:
            NameFull: Richard VR
      – PersonEntity:
          Name:
            NameFull: Zahedi RP
      – PersonEntity:
          Name:
            NameFull: Borchers CH
      – PersonEntity:
          Name:
            NameFull: Johnson JD
      – PersonEntity:
          Name:
            NameFull: Wellberg EA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 08
              Text: 2023 Aug 22
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1465-542X
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research : BCR
              Type: main
ResultId 1